Holen Sie sich die Stockscreener-App
59.14
2.37%
1.37
Handel nachbörslich:
58.15
-0.99
-1.67%
Schlusskurs vom Vortag:
$57.77
Offen:
$58.39
24-Stunden-Volumen:
2.92M
Relative Volume:
0.46
Marktkapitalisierung:
$29.20B
Einnahmen:
$198.10B
Nettoeinkommen (Verlust:
$-6.45B
KGV:
-4.4993
EPS:
-13.1443
Netto-Cashflow:
$7.11B
1W Leistung:
+1.49%
1M Leistung:
+51.91%
6M Leistung:
+62.03%
1J Leistung:
+1.84%
1-Tages-Spanne:
$58.11
$59.20
1-Wochen-Bereich:
$57.22
$60.76
52-Wochen-Spanne:
$25.07
$60.76
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
59.14 | 28.53B | 198.10B | -6.45B | 7.11B | -13.14 |
UNH
Unitedhealth Group Inc
|
388.47 | 347.35B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
93.26 | 119.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
394.69 | 84.65B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
286.24 | 74.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
307.95 | 36.46B | 137.20B | 1.15B | 1.27B | 9.3439 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Centene Corp. stock (US15133V1035): Medicaid specialist tightens 2026 outlook after strong quarter - AD HOC NEWS
Centene Analyst Ratings and Price Targets | NYSE:CNC - Benzinga
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
CNCCentene Corp Stock Price and Quote - Finviz
CNC Maintained by UBS -- Price Target Raised to $61.00 - GuruFocus
This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For FridayCentene (NY - Benzinga
This Q32 Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
CNC Stock Price, Quote & Chart | CENTENE CORP (NYSE:CNC) - ChartMill
Centene stock (US15133V1035): Bank of America lifts target as managed-care outlook shifts - AD HOC NEWS
Centene stock (US15133V1035): Bank of America lifts target as managed-care outlook improves - AD HOC NEWS
CNC Stock Quote Price and Forecast - CNN
CNC Maintained by B of A Securities -- Price Target Raised to $7 - GuruFocus
Centene’s SWOT analysis: managed care stock faces enrollment headwinds - Investing.com
Centene Corp. stock (US15133V1035): Mizuho lifts target as investors weigh managed-care outlook - AD HOC NEWS
How New Medicaid and Medicare Leadership at Centene (CNC) Has Changed Its Investment Story - simplywall.st
Centene Corp. stock outperforms competitors despite losses on the day - MarketWatch
CNC Maintained by Mizuho -- Price Target Raised to $58 - GuruFocus
Deutsche Bank upgrades Centene stock rating on earnings recovery - Investing.com
Deutsche Bank upgrades Centene stock rating on earnings recovery By Investing.com - Investing.com Canada
Deutsche Bank upgrades Centene (CNC) - MSN
Centene Corp. stock (US15133V1035): Q1 2026 earnings highlight medical cost trends - AD HOC NEWS
Centene Corp. stock (US15133V1035): Q1 2026 earnings highlight scale and cost focus - AD HOC NEWS
Centene Corp. stock (US15133V1035): first-quarter 2026 results put medical costs and margins in focu - AD HOC NEWS
Why Is Centene Stock Trending Across Healthcare - Kalkine Media
Centene stock (US15133V1035): Health insurer faces renewed scrutiny after first-quarter 2026 results - AD HOC NEWS
Centene Corporation (CNC) Announces Key Executive Appointments a - GuruFocus
Centene stock (US15133V1035): Earnings, Medicaid dynamics and outlook for US healthcare investors - AD HOC NEWS
Centene (CNC) price target increased by 23.07% to 57.73 - MSN
Centene Corp stock (US15133V1035): 6% surge to $59.31 - AD HOC NEWS
Easing medical costs a positive for health insurers, but real test lies ahead, analysts say - Reuters
Centene Corp stock (US15133V1035): Shares surge 6% to $59.31 - AD HOC NEWS
Centene Corp stock (US15133V1035): 6% surge to $59.31 on May 12 - AD HOC NEWS
1CNC.MI Technical Analysis | Trend, Signals & Chart Patterns | CENTENE CORP (BIT:1CNC) - ChartMill
A Look at Centene Corp (CNC) After 6.0% Gain -- GF Value $84.31 vs Price $59.31 - GuruFocus
Is Centene Corporation (CNC) One of the Best Healthcare Stocks to Buy for the Long Term? - Insider Monkey
Acadia Healthcare, Centene long picks by Greenlight's Einhorn at Sohn conf (ACHC:NASDAQ) - Seeking Alpha
Coordinated Care and Seattle Seahawks Host Youth Mental Health Summit - Yahoo Finance
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Centene Corp stock (US15133V1035): Q1 2026 earnings show $3.11 GAAP EPS - AD HOC NEWS
5 Best Healthcare Stocks to Buy for the Long Term - Insider Monkey
Centene Corp. stock (US15133V1035): Analysts lift price targets amid Medicaid headwinds and margin r - AD HOC NEWS
Centene Corp (CNC) Stock Price, Quote, News & History - Benzinga
Has Centene (CNC) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Is Wall Street Bullish or Bearish on Centene Stock? - Barchart.com
Centene (CNC) tops Q1 earnings and revenue estimates - MSN
Bernstein raises Centene stock price target to $68 on Medicaid outlook By Investing.com - Investing.com India
Centene Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Bernstein raises Centene stock price target to $68 on Medicaid outlook - Investing.com Canada
3 Texas providers receive designation to streamline Medicaid youth care - Stock Titan
This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here’s how - Yahoo Finance
Centene (CNC) Is Up 22.6% After Strong Q1 Beat And Raised 2026 OutlookWhat's Changed - Yahoo Finance
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):